FUSION ANTIBODIES PLC — Investor Relations & Filings
Fusion Antibodies PLC is a contract research organization (CRO) that provides a comprehensive suite of services for the discovery, engineering, and supply of preclinical biologics. The company offers an integrated, end-to-end antibody development platform, spanning from initial antigen design and antibody generation to advanced engineering processes like humanization and affinity maturation. It also provides services for the supply of recombinant proteins and antibodies, including stable cell line development. Fusion Antibodies supports therapeutic and diagnostic programs, operating as a collaborative partner to guide projects through critical preclinical stages with a focus on long-term manufacturability and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [accounts-balance-sheet] | 2017-12-11 | English | |
| Full accounts made up to 2017-03-31 | 2017-12-04 | English | |
| Small company accounts made up to 2016-03-31 | 2017-01-11 | English | |
| Small company accounts made up to 2015-03-31 | 2015-12-23 | English | |
| Full accounts made up to 2014-03-31 | 2014-12-23 | English | |
| Full accounts made up to 2013-03-31 | 2014-03-19 | English |
Browse filings by year
20 years- 2026 10 filings
- 2025 40 filings
- 2024 34 filings
- 2023 38 filings
- 2022 27 filings
- 2021 55 filings
- 2020 43 filings
- 2019 15 filings
- 2018 18 filings
- 2017 7 filings
- 2015 1 filing
- 2014 2 filings
- 2012 2 filings
- 2010 2 filings
- 2008 2 filings
- 2006 1 filing
- 2005 1 filing
- 2004 1 filing
- 2003 1 filing
- 2002 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2017
3 filings
| |||||
| 46835895 | [accounts-balance-sheet] | 2017-12-11 | English | ||
| 46835896 | Full accounts made up to 2017-03-31 | 2017-12-04 | English | ||
| 46835898 | Small company accounts made up to 2016-03-31 | 2017-01-11 | English | ||
|
2015
1 filing
| |||||
| 46835899 | Small company accounts made up to 2015-03-31 | 2015-12-23 | English | ||
|
2014
2 filings
| |||||
| 46835900 | Full accounts made up to 2014-03-31 | 2014-12-23 | English | ||
| 46835902 | Full accounts made up to 2013-03-31 | 2014-03-19 | English | ||
|
2012
2 filings
| |||||
| 46835903 | Full accounts made up to 2012-03-31 | 2012-12-28 | English | ||
| 46835904 | Full accounts made up to 2011-03-31 | 2012-02-02 | English | ||
|
2010
2 filings
| |||||
| 46835906 | Full accounts made up to 2010-03-31 | 2010-12-30 | English | ||
| 46835907 | Full accounts made up to 2009-03-31 | 2010-01-13 | English | ||
|
2008
2 filings
| |||||
| 46835908 | 31/03/08 annual accts | 2008-12-04 | English | ||
| 46835909 | 31/03/07 annual accts | 2008-02-19 | English | ||
|
2006
1 filing
| |||||
| 46835911 | 31/03/06 annual accts | 2006-11-08 | English | ||
|
2005
1 filing
| |||||
| 46835912 | 31/03/05 annual accts | 2005-12-20 | English | ||
|
2004
1 filing
| |||||
| 46835913 | 31/03/04 annual accts | 2004-07-22 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for FUSION ANTIBODIES PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
FUSION ANTIBODIES PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7655/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7655 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7655 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7655 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7655}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FUSION ANTIBODIES PLC (id: 7655)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.